BMC Nephrology (May 2017)

Serum micro-rna profiles in patients with autosomal dominant polycystic kidney disease according to hypertension and renal function

  • Ismail Kocyigit,
  • Serpil Taheri,
  • Elif Funda Sener,
  • Eray Eroglu,
  • Fahir Ozturk,
  • Aydin Unal,
  • Kezban Korkmaz,
  • Gokmen Zararsiz,
  • Murat Hayri Sipahioglu,
  • Yusuf Ozkul,
  • Bulent Tokgoz,
  • Oktay Oymak,
  • Tevfik Ecder,
  • Jonas Axelsson

DOI
https://doi.org/10.1186/s12882-017-0600-z
Journal volume & issue
Vol. 18, no. 1
pp. 1 – 10

Abstract

Read online

Abstract Background Autosomal dominant polycystic kidney disease (ADPKD) is a common hereditary disorder with unclear disease mechanism. Currently, overt hypertension and increased renal volume are the best predictors of renal function. In this study, we assessed the usefulness of selected circulating microRNAs (miRs) to predict disease progress in a cohort with ADPKD. Methods Eighty ADPKD patients (44.6 ± 12.7 years, 40% female, 65% hypertensive) and 50 healthy subjects (HS; 45.4 ± 12.7, 44% female) were enrolled in the study. Serum levels of 384 miRs were determined by Biomark Real Time PCR. Groups were compared using the limma method with multiple-testing correction as proposed by Smyth (corrected p 10% loss of GFR over the following 12 months (cut-off >2.2 AU, sensitivity 83%, specificity 78%, area 0.872 [95% CI: 0.790–0.953, p < 0.001]). Adjusting for age and starting CKD stage using multiple binary logistic regression analysis did not abrogate the predictive value. Conclusion Increased copy numbers of miR-3907 in the circulation may predict ADPKD progression and suggest pathophysiological pathways worthy of further study.